Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fennec Pharmaceuticals (FENC) Capital Expenditures (2024)

Fennec Pharmaceuticals (FENC) has disclosed Capital Expenditures for 4 consecutive years, with $1.7 million as the latest value for Q1 2024.

  • For the quarter ending Q1 2024, Capital Expenditures changed N/A year-over-year to $1.7 million, compared with a TTM value of $1.7 million through Jun 2024, changed N/A, and an annual FY2022 reading of $175000.0, changed N/A over the prior year.
  • Capital Expenditures was $1.7 million for Q1 2024 at Fennec Pharmaceuticals, up from $1.4 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $1.7 million in Q1 2024 and bottomed at $1.7 million in Q1 2024.